1-9 of 9
Sung Eun Lee, M.D
Close
Sort by
Journal Articles

Impact Of The Early Intensification Of Induction Chemotherapy On Complete Remission and Survival Rates For De Novo Adult Acute Myeloid Leukemia

Seung-Ah Yahng, Jae-Ho Yoon, MD, Sung-Eun Lee, M.D., Seung-Hwan Shin, Byung-Sik Cho, Ki-Sung Eom, Yoo-Jin Kim, Seok Lee, MD, PhD, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, MD, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park, Heeje Kim
Journal: Blood
Blood (2013) 122 (21): 3402.
https://doi.org/10.1182/blood.V122.21.3402.3402
Published: 2013
Journal Articles

Six-Year Follow-Up Of Dasatinib-Related Pulmonary Arterial Hypertension (PAH) For Chronic Myeloid Leukemia In Single Center

Young-Woo Jeon, M.D., Sung-Eun Lee, M.D., Soo-Hyun Kim, Soo-Young Choi, Jin-Eok Park, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4017.
https://doi.org/10.1182/blood.V122.21.4017.4017
Published: 2013
Journal Articles

Safety and Efficacy Of Imatinib In Elderly Patients With Chronic-Phase Chronic Myeloid Leukemia: Analysis Of Outcome For < 60 Years Versus ≥ 60 Years

Young-Woong Won, M.D., Ph.D., DongWook Kim, Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Eun-Jung Jang
Journal: Blood
Blood (2013) 122 (21): 4039.
https://doi.org/10.1182/blood.V122.21.4039.4039
Published: 2013
Journal Articles

Plasma Imatinib Trough Level Is a Predictor For 3-Month Early Molecular Response In New CP CML Patients

Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Yun Jeong Oh, Jin-Eok Park, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2716.
https://doi.org/10.1182/blood.V122.21.2716.2716
Published: 2013
Journal Articles

Kinetics Of Low-Level Mutant Clones Detected By Subcloning and Sequencing In Tyrosine Kinase Inhibitor Resistant CML

Soo-Hyun Kim, Soo Young Choi, Sung-Eun Lee, M.D., Yun Jeong Oh, Jin-Eok Park, Hae Lyun Yoo, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2720.
https://doi.org/10.1182/blood.V122.21.2720.2720
Published: 2013
Journal Articles

Nilotinib Or High-Dose Imatinib Compared With Standard-Dose Imatinib In Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses To Standard-Dose Imatinib: Including Updated Data From RE-Nice Study

Soo-Young Choi, Sung-Eun Lee, M.D., Yun Jeong Oh, Soo-Hyun Kim, Richard C. Woodman, Tomasz Szczudlo, Saengsuree Jootar, MD, Hyeoung-Joon Kim, MD, PhD, Sang Kyun Sohn, MD, PhD, Joon Seong Park, MD, Sung-Hyun Kim, MD, PhD, Dae-Young Zang, Suk-Joong Oh, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1499.
https://doi.org/10.1182/blood.V122.21.1499.1499
Published: 2013
Journal Articles

Predictive Factors For An Achievement Of 6-Month Early Molecular Response In New CP CML Patients Treated With Imatinib

Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Yun Jeong Oh, Jin-Eok Park, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5160.
https://doi.org/10.1182/blood.V122.21.5160.5160
Published: 2013
Journal Articles

Peripheral Arterial Occlusive Disease (PAOD) In Chronic Phase Chronic Myeloid Leukemia Patients Treated With Nilotinib

Young-Woo Jeon, M.D., Sung-Eun Lee, M.D., Soo-Young Choi, Soo-Hyun Kim, Jin-Eok Park, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4018.
https://doi.org/10.1182/blood.V122.21.4018.4018
Published: 2013
Journal Articles

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome with a Reduced Intensity Conditioning Regimen Consisting of Intravenous Busulfan, Fludarabine, and 400 Cgy Total Body Irradiation.

Sung Eun Lee, M.D, Yoo Jin Kim, MD, Seok Goo Cho, Byung Sik Cho, Ki-Seong Eom, Hee Je Kim, Seok Lee, Chang-Ki Min, MD, Dong Wook Kim, Jong Wook Lee, Woo Sung Min, Chong Won Park, Chun Choo Kim
Journal: Blood
Blood (2009) 114 (22): 4327.
https://doi.org/10.1182/blood.V114.22.4327.4327
Published: 2009